This notion is consistent with the frequently observed clinical scenario where CF patients can remain well for prolonged periods but nevertheless succumb rapidly post-infection with a sustained rise in inflammation that fails to abate without therapy; an established clinical observation which we explain by suggesting that the loss of wt-CFTR in a CF patient prevents a return to baseline inflammatory signalling. The gene discussed is CFTR; the disease is cystic fibrosis.